Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intraoperative Administration of Dexmedetomidine, Propofol and Midazolam on Postoperative Levels of Inflammatory Markers and Development of Postoperative Cognitive Dysfunction After Pertrochanteric Fracture Surgery.

NCT05398757 is registered in ClinicalTrials.gov with Osijek University Hospital as lead sponsor.

NCT NCT05398757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05398757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intraoperative Administration of Dexmedetomidine, Propofol and Midazolam on Postoperative Levels of Inflammatory Markers and Development of Postoperative Cognitive Dysfunction After Pertrochanteric Fracture Surgery.
Lead sponsor
Osijek University Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
July 1, 2022
Completion date
March 1, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pertrochanteric fracture, postoperative cognitive dysfunction, postoperative pain, acute